NCT07435129Phase 2Recruiting

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

Study sponsor: Scholar Rock, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-06Estimated
Enrollment · participants60Estimated
Source updated2026-09-02Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source